Background: Diabetic Peripheral Neuropathy (DPN) is an important micro-vascular complication of Diabetes Mellitus (DM), considered as a major contributor to foot ulceration and lower limb amputation among diabetic patients and have remarkable negative effect on patient's quality of life.
Introduction
DIABETES Mellitus (DM) is a complex metabolic disorder that is manifested by chronic hyperglyc-Correspondence to: Dr. Balqis A. Abdulla Ebrahim, The Department of Internal Medicine, Faculty of Medicine, Aden University, Yemen emia. It results in disturbances of carbohydrate, fat and protein metabolism as a consequence of defects in insulin secretion, insulin action, or both. Diabetic progression leads to severe diabetes complications such as retinopathy, neuropathy, nephropathy, cardiovascular complications and ulceration [1] .
Chronic peripheral sensorimotor symmetrical neuropathy accounts for approximately 75% of the diabetic neuropathies [2] . It is defined as the presence of symptoms and/or signs of peripheral nerve dysfunction in people with DM, after exclusion of other causes [3] . The primary symptom of DPN is loss of sensation in the toes, which extends to involve the feet and leg in a stocking distribution. Some patients complain about numbness and pain, but most frequently the disease progresses insidiously and undetected. If no action is taken, foot callus, ulceration and infection might develop and further turn into distressing and painful impairment. The foot ulcers among diabetic patients are mostly of neuropathic origin, and therefore eminently preventable [4] .
Neuropathy and neuropathic pain are among the strongest determinants of reduced health-related quality of life in patients with type 2 diabetes mellitus. Also, neuropathy management including adequate podiatric care in patients with type 2 diabetes mellitus adds on to the economic burden of the national health system [5] .
Different mechanisms have been implicated in the development of diabetic neuropathy. The most important initiator of the process is probably hyperglycemia. Mechanisms of glucose neurotoxicity include accumulation of sorbitol via the enzyme aldolase reductase and glucose driven oxidative stress subsequently leading to structural changes 2935 Various clinical composite scores have been developed to assess DPN. These include Neuropathy Symptom Score (NSS), Diabetic Neuropathy Examination (DNE), Neuropathy Disability Score (NDS), Michigan Neuropathy Screening Instrument (MNSI) and Total Symptom Score (TSS) [8] . The reliability of scoring symptoms and clinical findings in patients with suspected peripheral neuropathy can be high if the examiner is well trained and the scales are well defined [9] .
The gold standard for detecting DPN is the nerve conduction velocity. It can diagnose sensory and motor losses due to neuropathy even when dysfunction is subclinical, and it can predict ulceration and mortality in diabetic patients. However, it is not commonly available in public health units [10] .
Patients and Methods
Around six months duration, during the period from January to June 2015. The present retrospective cross-sectional study was carried out on 124 diabetic patients conducted an outpatient setting of diabetic center in Aden governorate, Yemen to estimate the prevalence and possible risk factors of DPN. Data collected from patient's full medical records were selection considered to be of both types of diabetic (insulin and non-insulin dependent) with 5-20 years duration of diabetes. Measurement of blood pressure, waist circumference, BMI, and ophthalmologic examination which evaluated by fundoscopy. Para clinical investigations included Fasting Blood Sugar (FBS), Glycated hemoglobin (HbA 1 c ), renal function test (urea and creatinine), lipid profile, electrocardiogram, 24-h protein excretion ( ≥500mg/day), urine for albuminuria and urine Albumin Creatinine Ratio (UACR). Diabetic Peripheral Neuropathy (DPN) involving distal limbs (after the exclusion of other causes) was assessed by clinical peripheral neuropathy scoring systems (neuropathy symptoms and disability scoring). Neuropathy symptom score NSS (5 questions) assigning points symbolized by 2p, 1p, 0p were total maximum abnormal symptom score was 9 points (3-4 mild, 5-6, moderate and 7-9 sever) and neuropathy disability score NDS (4 tests) symbolized by 2p, 1p, 0p were total maximum abnormal disability score was 10 points (3-5 mild, 6-8 moderate and 9-10 sever) in which the minimum acceptable criteria for diagnosis of diabetic peripheral neuropathy included moderate disability with or without symptoms, or mild disability with moderate symptoms.
Criteria included in this study were patients with diabetes mellitus were diagnosed based on American Diabetic Association criteria, fasting blood sugar of 126mg/dl or random blood sugar of 200mg/dl or more, or glycated hemoglobin 6.5% or more. While the excluded criteria were patients with history of familial or inherited neuropathies, alcohol ingestion, patients on dialysis, receiving chemotherapy therapy or other drugs that may cause neuropathy, HIV treatment, hypothyroidism and foot ulcer or imputation.
Statistical analysis:
Data processing was performed by the computer software program of the Statistical Package for Social Sciences (SPSS) Version 20. Categorical variables were expressed as frequencies, continues variables as mean ± standard deviation, chi-square to evaluate potential association between categorical variables and student's t-test to compare between means. Odds Ratios (OR) with 95% Confidence Interval (CI) were provided. p<0.05 was taken as significant.
Results
This study included 124 patients with diabetes mellitus conducted at Aden Diabetes Center during the study period from 1 st January to 30th June 2015. There were 70 (56.5%) female and 54 (43.5%) male subjects with age ranges from 18 to 70 years with mean of 51.0 ± 11.6 years.
Statistical significant relationship between age and DPN (p 0.009) were increasing in prevalence of DPN with increased age was observed from (64%) in those aged (50-64) years to (90%) in those aged ≥65 years. On the other hand; young patients not complicated by DNP aged <20 years presented with highest percentage (100%). Statistical significant not found in related to the gender and DPN where found slight higher in percentage of affected female patients (64.3%) Vs. (55.6%) for males (p 0.32). Illiterate patients showed increasing in percentage (80.8%) of DPN, while patients with tertiary level of education had percentage (62.5%) without DPN. There was a statistical significant (p 0.013) of DPN in relation to education level. Social habit (smoker and khat chewing) showed no statistical significant in studied patients with DPN in compare to studied patients without DPN (p 0.158, 0.077 respectively).
Glycemic control HbA1 c :
Good Balqis A. A. Ebrahim, et al. 2937 Studied patients with T2DM had a higher prevalence of DPN than studied patient with T1DM (64.5% Vs. 35 .5%), such difference was statistically significant (p 0.022). No statistical significant (0.156) found in relation to DPN and family history of DM in studied patients, while statistical significant (p 0.001) found in relation to the duration of DM, where the prevalence of DPN is increased with longstanding DM where found higher among those with duration 10-20 years (80%) and (60.4%) with duration <5 years among studied patients without DPN. No statistical significant (p 0.197) found in relation to DPN and HbA1c among studied patients (65.5%), with DPN and poor glycemic control HbA 1c (>9%) in compare to prevalence of studied patients without DPN (58.8%) and good glycemic control (<7%) there was no statistical significant (p 0.119) found in relation to DPN and type of diabetic treatment among studied patients, where (80%) as high percentage among studied patient with DPN on hypoglycemic and insulin therapy, while (52%) as high percentage among studied patients with no DPN on insulin therapy. Compared laboratory data between patients with and without DPN, where showed that no difference in means of laboratory data (fasting blood sugar, HbA 1c , serum urea, serum creatinine and lipid profile) as well no statistical significant in relation to studied patients with and without DPN. Dyslipidemia in studied patients with DPN was with high prevalence (71.4%) in compare to studied patients without DPN (28.6%) with significant statistic (p 0.011). Studied patients with DPN and arterial hypertension (66.7%) showed no statistical significance (0.194) in compare to studied patients with DPN and normotensive (55.2%). Ischemic Heart Disease (IHD) showed no statistical significant (p 0.605) in studied patients with DPN (53.8%) and those without DPN (61.3%).
Predictors for developing DPN appeared to be significant and independently associated with DPN, were odd ratio in low educational level (8.75 times), dyslipidemia (1.97 times), the duration of diabetes (1.14 times) and waist circumference (1.05 times). The simple regression analysis of microvascular complications in relation to DPN among the studied patients revealed an increased risk for the development of DPN in patients with abnormal fundus examination with a significant risk of 2.96 times (OR 2.96, 95% CI 1.25-6.98).
Discussion
Diabetic Peripheral Neuropathy (DPN) is the most commonly reported long-term diabetic complication, affecting up to 50% of diabetic patients [11] . Prevalence rates of DPN varies from 5-100%, [12] this wide range may reflect the diverse study population, different types of diabetes mellitus [13] .
In our study, 124 patients were selected from registered patients in Aden Diabetic Center; were DPN assessed by NSS and NDS, the prevalence of DPN was (60.48%), in compared with other studies that used same scores in assessment, nearly similar prevalence were found by Borü et al., (60%) [14] and by Mimi et al., (50.7%) [15] while higher than that reported by Jarso et al., (48.2%) [16] and Young et al., (28.5%) [17] , and less in compared with Nadir et al., (66.5%) [18] . Prevalence of DPN in another studies done by Gunaid et al., [19] who depended on assessment of the peripheral neuropathy on subjective and objective criteria, as well p OR 95%CI
Al-Washali et al., [20] who assessed by clinical scores were (66.5%, 56.2% respectively).
Possible explanation of high prevalence of diabetic peripheral neuropathy in our study was that, 44.4% of the studied population had poor glycemic control HbA 1c >9 while only 13.7% had good glycemic control HbA 1c <7.
The mean age of our study population was 51.0± 11.6 years which was nearly equal to the mean age reported by Kiani et al., [21] (53.2± 14.4 years), Wang et al., [22] (53.4± 10.5 years) and Al-Washali et al., [20] (53.5 ± 11. 1 years).
In the developing countries, the majority of diabetic patient are in the age range 45-64 years [23] . In the present study, a significant number of study population were in the age group (50-64) years (56.5%), while the least frequent age group was patient <20 years (1.6%). Similar results were obtained by Nadir et al., [18] .
In this study, a significant relation was found between DPN and age of patient ( p 0.009); neuropathy increased progressively with increasing age reaching maximum frequency of 90% in patient aged >65 years followed by 64% in patient aged (50-64) years. Moreover, DPN was absent in younger age groups <20 years, same significant association found in studies conducted by Young et al., [17] Boru et al., [14] and Mimi et al., [15] .
In addition, the mean age of patients with DPN was significantly higher than that of patient without DPN (53.6±9.9 Vs. 46 The sex distribution in our study showed female preponderance (56.5%) which is similar to female preponderance reported by Al-Washali et al., [20] , in other studies observed that, male being at higher risk of DPN in the diabetic control and complication Trail [25] and although female population were greater (64.3%), gender has non-significant impact on frequency of DPN in our study. The present observation was supported by Kasim et al., [26] Increasing educational level was linked with better health care and self-care knowledge and practice [27] . In the present study, DPN was significantly associated with patient's educational level ( p 0.013), illiterate patients had the highest frequency of DPN 80% while highly educated subject appear to be protected from DPN with the least frequency 37.5%. Our result is in agreement with Caliskan et al., [27] .
In this study, the overall prevalence of DPN in T2D patients (64.5%) was significantly higher than that in T1DM patients (35.3%) ( p 0.022). This high prevalence among T2D was also reported by others studies as Nadir et al., (69%) [18] , Al-Washali et al., (57.9%) [20] and Kiani et al., [21] . This trend may be related to late diagnosis or the long prodromal period between the onset and the diagnosis of T2D. Our result is not similar to Jambart et al., [28] and Wang et al., [22] both determine T1D as a significant risk factor for DPN.
The mean duration of diabetes in this study population was (8.47 ±6.8) years, which is similar to that reported by Mimi et al., from [15] Cigarette smoking was found to be associated with an increased risk of DPN in some of the previous studies [30] . In the present study, however, no significant relationship was observed between DPN and current smoking (37.5%). Wang et al., in [22] , and Ali et al., [31] also found no significant relation between smoking and DPN. Most of our patients were nonsmokers (93.5%), which may affect the result.
In the international literature, no adequate information available about Khat chewing and DPN. In our study, Khat chewing had nonsignificant effect on DPN (50%). Our result is not similar to Ali et al., [31] where DPN was significantly associated with Khat chewing. The present data show that patients reported positive family history of DM were found to have higher frequency of DPN, as compared with those without a family history of diabetes mellitus (64.5% Vs. 51 .3%) but this relation was statistically non-significant, likewise, Janghorbani et al., [32] and Al-Kaabi et al., [33] reported similar results. However, JI Na et al., [34] and Kasim et al., [26] found that family history of DM is a significant predictor for DPN. Moreover, Amjad et al., [35] found that the prevalence of diabetic complication was low among patient with family history of diabetes as compared to diabetic patient without family history.
HbA 1c being the highest among our patients with poor glycemic control (65.5%). However, this relation was statistically non-significant ( p 0.197), similar findings were observed in different studies as Janghorbani et al., [32] and Wang et al., [22] . Possible explanation is that single blood result of HbA 1c is a poor indicator of the overall diabetic control.
In the current study, patients treated with insulin and oral anti-diabetic drugs had the highest frequency of DPN (80%), however, type of therapy had non-significant impact on the development of DPN (p 0.119). Similar results were observed in other studies as JI Na et al., [34] and Al-Kaabi et al., [33] while not in agreements with other studies as Tamer et al., [36] and Davis et al., [37] all these studies associate DPN with insulin use. Some of those studies postulated that exogenous insulin therapy might be associated with DPN through an exacerbation of obesity, fluid retention, hypertension and hyperlipidemia or even insulin induced neuritis [32] . In our study, we found that diabetic patient with dyslipidemia had significantly higher risk of diabetic peripheral neuropathy (71.4%) ( p 0.011). Our results were in accordance with many other studies as Jambart et al., (59%) [28] , Preeti et al., (58%) [38] . It also correspond to Won et al. [39] . A prospective study of patients with idiopathic neuropathy confirmed a higher prevalence of hyperlipidemia than impaired glucose tolerance or hypertension, also suggesting that hyperlipidemia is an essential factor underlying nerve injury [40] .
In our study, despite the existence of a positive association between hypertension and DPN, it was statistically not significant (66.7% Vs. 55.2%). Our result is similar to Al-Washali et al., (64% Vs. 53%) [20] . It is also in agreement with Borü et al., [14] and Shaw et al., [40] . Hypertension had emerged as a significant risk factor for DPN in other studies as Prasad et al. [29] .
Patients presenting with cardiovascular disease are at increased risk of DPN [34] . In our study, both patients with and without IHD show high frequency of DPN (53.8% Vs. 61.3%), although this association was not significant (p>0.05). Our findings were in agreement with Nadir et al., [18] and JI Na et al., [34] Nevertheless, it is not similar to Jambart et al., [28] and Janghorbani et al., [32] . Data from the current study suggested that abdominal obesity defined by waist circumference was significant with DPN (p 0.001). These findings were in agree-ment with. Ziegler et al., study, [41] who reported a positive association between waist circumference and DPN as well as Wang et al., [22] and Al-Mahroos et al., [42] . However, in Tapp et al., study [43] and Bansal et al., in their studies, [13] found no significant association between waist circumference and DPN. Insulin resistance is more strongly related to abdominal obesity than general obesity. Previous studies suggest that insulin resistance is associated with DPN and autonomic function impairment [44] .
BMI is a standard unit for quantifying obesity [45] . Our study found that, patients with DPN had higher mean (BMI) than patients without DPN ( p 0.036). Similar finding was observed with Tesfaye in prospective complications study, [46] Jambart et al., [28] and Al-Mahroos et al., [42] where obesity was a significant risk factor for DPN. However, Katulanda et al., [24] found that obese patients had lower prevalence of DPN compared with nonobese patients.
It has been widely recognized that poor glycemic control is an important risk factor for neuropathy [46] . In this study, patients with DPN had higher mean HbA 1c levels compared with those without neuropathy, but this was no statistically significant, this finding supported the same observations in many studies as Bansal et al., [13] , Booya et al., [47] and Partanen et al., [48] . Yüksel et al., [49] where HbA 1c was significantly associated with DPN. This may be because most of patients were already on treatment at the time of the study (98.5%).
In this study, patients with DPN had higher fasting blood sugar levels compared with those without neuropathy, but this was not statistically significant. A similar finding was observed in several studies as in Zhang et al., [50] and Pradeepa et al., [51] . Moreover, the Fremantle Diabetes Study that has done in Australia [18] , Wang et al., in [22] and Partanen et al., [48] reported that DPN was significantly related to increase fasting blood sugar.
In this study, participants with higher levels of urea had high percentage of DPN with nonsignificant relation (p>0.05). Our result is in agreement with Wang et al., in [22] and JI Na et al., [34] while Aguiar et al., [52] and Zhang et al., [50] , were they found that, patients with DPN had higher urea compared to patients without DPN but with significant association. In addition, our study showed that creatinine level had non-significant association with DPN (p 0.231). This finding correspond to JI Na et al., [34] and Aguiar et al., [52] in contrast, Wang et al., from [22] and Zhang et al., [53] reported that higher creatinine level was as a significant risk factor for DPN.
The present study has accounted for lipid profile as tested for its association with DPN, were mean of lipid profile showed no significant difference between patient with and without DPN. Concordant results were found by other studies as JI Na et al., [34] and Davis et al., [37] .
Relation between the prevalence of DPN in individuals with and without retinopathy was also studied to establish a relation between the two. In the present study, patients with non-proliferative and proliferative retinopathy had significantly high frequency of DPN (80% and 71%) respectively compared with patients with no retinopathy (52%) (p 0.035).Similarly, Ali et al., [31] and Won et al., [39] concluded that neuropathy was seen more in patients with coexisting retinopathy. JI Na et al., [34] . Abougalambou et al., [53] and Janghorbani et al., [32] proved retinopathy to be an independent risk factor for diabetic neuropath.
The association of DPN with nephropathy has been variably present [28, 39] . In this study we found a numerical higher frequency of DPN among patients with micro-albuminuria and macroalbuminuria (71% and 100%) more than patients with no albuminuria (58.7%), but we couldn't identify it as significant predictor (p 0.473). Our result was in concurrent with Pradeepa et al., [51] and Barbosa et al., [54] but it is not similar to Jambart et al., [28] where nephropathy emerged as a significant risk factor for DPN. The high frequency of DPN among patients with macro-albuminuria is duo to small sample size. Only one patient in our study had macro-albuminuria and DPN. This may be explained by the fact that patients with more severe renal impairments were excluded from the study. The association between DPN with albuminuria is of potential importance, UACR is a sensitive indicator of DPN even with mild abnormal rang [51] . On the other hand this association may be used to support the micro-vascular hypothesis in the pathogenesis of diabetic neuropathy in that micro-albuminuria, as a marker for early nephropathy, has undoubted micro-vascular etiology [47] .
Simple logistic regression analysis showed an expected pattern of association for many variables with DPN. These variables are age; educational level, abdominal obesity, T2D, longer DM duration,dyslipidemia and retinopathy. In multivariate analysis, fewer remain independently associated with DPN. In the current study, the odds of having neuropathy were greater among those with low educational level compared with those completed university education. This concurs with many studies conducted elsewhere lower level of education may be a marker of lower socioeconomic status, which in turn may be associated with poorer access to health care services and self-care practices [55] . Consistent with prior studies, the present study confirms the well-established association between the prevalence of DPN and duration of diabetes as an independent risk factor [56] in all these studies, development of peripheral neuropathy showed a progressive increase with increased duration of diabetes. The independent association observed between DPN and the presence of dyslipidemia have previously described [49] . As well as the independent association between abdominal obesity and DPN [57] .
Conclusion and Recommendation:
Based on the findings of this study Illiteracy, abdominal obesity, longer duration of diabetes and dyslipidemia are most important predictors of diabetic peripheral neuropathy. We recommended for more adherence to strict glycemic control as well raising the education level with good awareness about diabetic mellitus as the key in delay development of diabetic neuropathy and it's complication.
